The existence of endogenous benzodiazepines such as diazepam and nordiazepa
m has been provided in human blood and brains as well as in medicinal plant
s and foods. It must be stressed, however, that in plasma and brain tissue
there are also other benzodiazepine-like compounds termed 'endozepines' whi
ch are not halogenated. A synthetic pathway for the production of benzodiaz
epine-like compounds and endozepines has not yet been found, hence it may b
e surmised that these compounds could be: of exogenous source. Changes in t
he level of endogenous circulating benzodiazepines due to food or drug inge
stion could be responsible for pathological conditions. Clinical experiment
s were designed in order to study the levels of the endogenous benzodiazepi
nes in vegetables and in the blood of control subjects and of cirrhotic pat
ients. These patients accumulate benzodiazepines because of decreased liver
metabolization capacity and impaired renal secretion, reaching plasma conc
entrations similar to those recorded in commercial benzodiazepine consumers
.